BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34328259)

  • 1. Primary sclerosing cholangitis with moderately elevated serum-IgG4 - characterization and outcome of a distinct variant phenotype.
    Zhou T; Lenzen H; Dold L; Bündgens B; Wedemeyer H; Manns MP; Gonzalez-Carmona MA; Strassburg CP; Weismüller TJ
    Liver Int; 2021 Dec; 41(12):2924-2933. PubMed ID: 34328259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.
    Boonstra K; Culver EL; de Buy Wenniger LM; van Heerde MJ; van Erpecum KJ; Poen AC; van Nieuwkerk KM; Spanier BW; Witteman BJ; Tuynman HA; van Geloven N; van Buuren H; Chapman RW; Barnes E; Beuers U; Ponsioen CY
    Hepatology; 2014 May; 59(5):1954-63. PubMed ID: 24375491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.
    Oseini AM; Chaiteerakij R; Shire AM; Ghazale A; Kaiya J; Moser CD; Aderca I; Mettler TA; Therneau TM; Zhang L; Takahashi N; Chari ST; Roberts LR
    Hepatology; 2011 Sep; 54(3):940-8. PubMed ID: 21674559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD; Jorgensen R; Keach J; Katzmann JA; Smyrk T; Donlinger J; Chari S; Lindor KD
    Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
    Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
    J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
    Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of primary sclerosing cholangitis with increased IgG4 levels.
    Manganis CD; Chapman RW; Culver EL
    World J Gastroenterol; 2020 Jun; 26(23):3126-3144. PubMed ID: 32684731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease.
    Alderlieste YA; van den Elzen BD; Rauws EA; Beuers U
    Digestion; 2009; 79(4):220-8. PubMed ID: 19390194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
    Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
    Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4-Associated Cholangitis--A Mimic of PSC.
    Beuers U; Hubers LM; Doorenspleet M; Maillette de Buy Wenniger L; Klarenbeek PL; Boonstra K; Ponsioen C; Rauws E; de Vries N
    Dig Dis; 2015; 33 Suppl 2():176-80. PubMed ID: 26641633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis with increased immunoglobulin G4 levels: A case report.
    Chen QL; Zhong R; Zhang XX; Feng LN; Wen XY; Jin QL
    Medicine (Baltimore); 2019 Dec; 98(50):e18411. PubMed ID: 31852163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
    Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
    Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
    Farahmand F; Ahmadi M; Khodadad A; Najafi M; Fallahi G; Motamed F; Movahedi M; Aghamohammadi A; Rezaei N; Javaherizadeh H
    Clin Exp Hepatol; 2019 Nov; 5(4):285-288. PubMed ID: 31893239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Choudhary M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Mar; 7(2):e35-41. PubMed ID: 22554774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis.
    Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Ohara H; Joh T
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1104-9. PubMed ID: 25594435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy.
    Björnsson E; Chari S; Silveira M; Gossard A; Takahashi N; Smyrk T; Lindor K
    Am J Ther; 2011 May; 18(3):198-205. PubMed ID: 20228674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4-associated cholangitis.
    Nath V; Lewin J; Subramony C; Shenoy V
    J Miss State Med Assoc; 2014 Dec; 55(12):384-8. PubMed ID: 25799760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of IgG4-related sclerosing cholangitis.
    Nakazawa T; Naitoh I; Hayashi K; Miyabe K; Simizu S; Joh T
    World J Gastroenterol; 2013 Nov; 19(43):7661-70. PubMed ID: 24282356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
    Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
    World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.